Does Renal Function Influence Plasma Levels of Advanced Glycation and Oxidation Protein Products in Patients with Chronic Rheumatic Diseases Complicated by Secondary Amyloidosis?

Publisher： Karger

E-ISSN： 1423-0143|30|1|1-7

ISSN： 1420-4096

Source： Kidney and Blood Pressure Research, Vol.30, Iss.1, 2006-12, pp. : 1-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advanced Glycation End Products and Advanced Oxidation Protein Products in Hemodialyzed Patients

By  

Blood Purification, Vol. 20, Iss. 6, 2003-01 ,pp. : 531-536

Karger

Access to resources Recommend Favorite

Impact of Angiotensin II Receptor Blocker on Plasma Levels of Adiponectin and Advanced Oxidation Protein Products in Peritoneal Dialysis Patients

By  

Blood Purification, Vol. 24, Iss. 5-6, 2006-12 ,pp. : 445-450

Karger

Access to resources Recommend Favorite

Pregnancy-Associated Plasma Protein A and Soluble Receptor for Advanced Glycation End Products after Kidney Transplantation

By  

Kidney and Blood Pressure Research, Vol. 30, Iss. 1, 2007-01 ,pp. : 31-37

Karger

Access to resources Recommend Favorite

Genetic Predisposition to Advanced Glycation End Products Toxicity Is Related to Prognosis of Chronic Hemodialysis Patients

By  

Kidney and Blood Pressure Research, Vol. 33, Iss. 1, 2010-02 ,pp. : 30-36

Karger

Access to resources Recommend Favorite

Advanced Glycation End Products in End-Stage Renal Disease and Their Removal

By  

Nephron, Vol. 87, Iss. 4, 2001-03 ,pp. : 295-303

Karger

Access to resources Recommend Favorite